Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in Focus – Zacks.com
|
Ophthotech (OPHT) Q4 Earnings Beat, Gene Therapy in Focus
Zacks.com Our experts cut down 220 Zacks Rank #1 Strong Buys to the 7 that are most likely to jump in price immediately. For 28 years, the full Strong Buy list has averaged a stellar +25% per year. See its 7 best stocks now. Privacy Policy | No cost, no … |
